7VMP image
Entry Detail
PDB ID:
7VMP
EMDB ID:
Title:
Structure of recombinant RyR2 (Ca2+ dataset, class 2, open state)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-10-09
Release Date:
2022-08-10
Method Details:
Experimental Method:
Resolution:
3.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ryanodine receptor 2
Chain IDs:A, C (auth: B), E (auth: C), G (auth: D)
Chain Length:4966
Number of Molecules:4
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Peptidyl-prolyl cis-trans isomerase FKBP1B
Chain IDs:B (auth: G), D (auth: H), F (auth: I), H (auth: J)
Chain Length:176
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations.
Nat Commun 13 2821 2821 (2022)
PMID: 35595836 DOI: 10.1038/s41467-022-30429-x

Abstact

Cardiac ryanodine receptor (RyR2) is a large Ca2+ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca2+ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remains unknown. Here, we address the gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca2+ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.

Legend

Protein

Chemical

Disease

Primary Citation of related structures